Skip to main content
Top
Published in: Rheumatology International 9/2008

01-07-2008 | Original Article

Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population

Authors: H. J. Lee, G. H. Lee, S. Nah, K. H. Lee, H. Yang, Y. M. Kim, W. Chun, S. Hong, S. Kim

Published in: Rheumatology International | Issue 9/2008

Login to get access

Abstract

Due to an imbalance in the MMP:TIMP ratio determined a tissue damage in arthritis, it is hypothesized that polymorphic variations of the TIMP genes are associated with regulation of the MMP:TIMP balance. To test this hypothesis, the presence of single nucleotide polymorphisms (SNPs) located in the human TIMP-2 and TIMP-4 genes was confirmed in the Korean RA and OA patients. We performed a case-control study comprising 109 unrelated Korean OA patients, 177 unrelated Korean RA patients and 175 healthy subjects. There were statistically significant differences in the genotype distribution and allele frequencies of the C/T polymorphism of TIMP-4 gene between OA and control groups (P = 0.0002 and P = 0.001, respectively). However, no significant association between TIMP-2 polymorphisms and OA was observed. Also, no difference was observed when allele or genotype frequencies of both TIMP-2 and TIMP-4 gene polymorphisms were compared between RA and controls. We demonstrated that the C/T polymorphism which is located on the 3′-untranslational regions of the TIMP-4 gene might be associated with susceptibility to OA patients.
Literature
1.
go back to reference Felson DT, Lawrence RC, Hochberg MC, McAlindon T, Dieppe PA, Minor MA, Blair SN, Berman BM, Fries JF, Weinberger M, Lorig KR, Jacobs JJ, Goldberg V (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635–646PubMed Felson DT, Lawrence RC, Hochberg MC, McAlindon T, Dieppe PA, Minor MA, Blair SN, Berman BM, Fries JF, Weinberger M, Lorig KR, Jacobs JJ, Goldberg V (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635–646PubMed
3.
go back to reference Sowers M (2001) Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol 13:447–451PubMedCrossRef Sowers M (2001) Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol 13:447–451PubMedCrossRef
4.
go back to reference Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D (1996) Genetic influences on osteoarthritis in women: a twin study. BMJ 312:940–943PubMed Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D (1996) Genetic influences on osteoarthritis in women: a twin study. BMJ 312:940–943PubMed
6.
go back to reference Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocyte of human osteoarthritic cartilage: association with degenerative changes. Arthritis Rheum 44:585–594PubMedCrossRef Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocyte of human osteoarthritic cartilage: association with degenerative changes. Arthritis Rheum 44:585–594PubMedCrossRef
7.
go back to reference Solovieva S, Hirvonen A, Siivola P, Vehmas T, Luoma K, Riihimaki H, Leino-Arjas P (2006) Vitamin D receptor gene polymorphisms and susceptibility of hand osteoarthritis in Finnis women. Arthritis Res Ther 8:R20PubMedCrossRef Solovieva S, Hirvonen A, Siivola P, Vehmas T, Luoma K, Riihimaki H, Leino-Arjas P (2006) Vitamin D receptor gene polymorphisms and susceptibility of hand osteoarthritis in Finnis women. Arthritis Res Ther 8:R20PubMedCrossRef
8.
go back to reference Mustafa Z, Chapman K, Irven C, Carr AJ, Clipsham K, Chitnavis J, Sinsheimer JS, Bloomfield VA, McCartney M, Cox O, Sykes B, Loughlin J (2000) Linkage analysis of candidate genes as susceptibility loci for osteoarthritis-suggestive linkage of COL9A1 to female hip osteoarthritis. Rheumatology 39:299–306PubMedCrossRef Mustafa Z, Chapman K, Irven C, Carr AJ, Clipsham K, Chitnavis J, Sinsheimer JS, Bloomfield VA, McCartney M, Cox O, Sykes B, Loughlin J (2000) Linkage analysis of candidate genes as susceptibility loci for osteoarthritis-suggestive linkage of COL9A1 to female hip osteoarthritis. Rheumatology 39:299–306PubMedCrossRef
9.
go back to reference Loughlin J, Sinsheimer JS, Mustafa Z, Carr AJ, Clipsham K, Bloomfield VA, Chitnavis J, Bailey A, Sykes B, Chapman K (2000) Association analysis of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic osteoarthritis. J Rheumatol 27:779–784PubMed Loughlin J, Sinsheimer JS, Mustafa Z, Carr AJ, Clipsham K, Bloomfield VA, Chitnavis J, Bailey A, Sykes B, Chapman K (2000) Association analysis of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic osteoarthritis. J Rheumatol 27:779–784PubMed
10.
go back to reference Cawston T (1998) Matrix metalloproteinases and TIMPs: proterties and implications for the rheumatic diseases. Mol Med Today 3:130–137CrossRef Cawston T (1998) Matrix metalloproteinases and TIMPs: proterties and implications for the rheumatic diseases. Mol Med Today 3:130–137CrossRef
11.
go back to reference Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283PubMed Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283PubMed
12.
go back to reference Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374–17378PubMed Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374–17378PubMed
13.
go back to reference Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA, Shi YE (1997) Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP4). J Biol Chem 272:20479–20483PubMedCrossRef Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA, Shi YE (1997) Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP4). J Biol Chem 272:20479–20483PubMedCrossRef
14.
go back to reference Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 61:3610–3618PubMed Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 61:3610–3618PubMed
15.
go back to reference Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr. (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678–685PubMedCrossRef Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr. (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678–685PubMedCrossRef
16.
go back to reference Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000) Matriz metalloproteinase and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455–461PubMedCrossRef Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000) Matriz metalloproteinase and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455–461PubMedCrossRef
17.
go back to reference Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Sieskiewicz E, Chwiecko J (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. J Rheumatol 33:1523–1529PubMed Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Sieskiewicz E, Chwiecko J (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. J Rheumatol 33:1523–1529PubMed
18.
go back to reference Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J (1994) Serum metalloproteinase and their inhibitors: markers for malignant potential. Br J Cancer 70:506–512PubMed Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J (1994) Serum metalloproteinase and their inhibitors: markers for malignant potential. Br J Cancer 70:506–512PubMed
19.
go back to reference Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J (2002) Serum metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid arthritis. Rheumatology (Oxford) 41:78–87CrossRef Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J (2002) Serum metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid arthritis. Rheumatology (Oxford) 41:78–87CrossRef
20.
go back to reference Huang W, Li WQ, Dehnade F, Zafarullah M (2002) Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 85:295–303PubMedCrossRef Huang W, Li WQ, Dehnade F, Zafarullah M (2002) Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 85:295–303PubMedCrossRef
21.
go back to reference Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG (2003) Functional polymorphisms in matix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 32:235–239PubMed Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG (2003) Functional polymorphisms in matix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 32:235–239PubMed
22.
go back to reference Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH (2004) Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 4:147–149CrossRef Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH (2004) Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 4:147–149CrossRef
23.
go back to reference Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G (2004) Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther 6:R199–R207PubMedCrossRef Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G (2004) Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther 6:R199–R207PubMedCrossRef
24.
go back to reference Zhao J, Hyman L, Moore C (1999) Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrlationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 63:405–445PubMed Zhao J, Hyman L, Moore C (1999) Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrlationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 63:405–445PubMed
25.
go back to reference Chen J, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet 120:1–21PubMedCrossRef Chen J, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet 120:1–21PubMedCrossRef
26.
go back to reference Chen J, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants. Hum Genet 120:301–333PubMedCrossRef Chen J, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants. Hum Genet 120:301–333PubMedCrossRef
27.
go back to reference Clements DN, Carter SD, Innes JF, Ollier WER, Day PJR (2006) Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative polymerase chain reaction. Arthritis Res Ther 8:1–9CrossRef Clements DN, Carter SD, Innes JF, Ollier WER, Day PJR (2006) Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative polymerase chain reaction. Arthritis Res Ther 8:1–9CrossRef
28.
go back to reference Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, Brockbank SM, Edwards DR, Parker AE, Clark IM (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50:131–141PubMedCrossRef Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, Brockbank SM, Edwards DR, Parker AE, Clark IM (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50:131–141PubMedCrossRef
29.
go back to reference Celiker MY, Ramamurthy N, Xu JW, Wang M, Jiang Y, Greenwald R, Shi YE (2002) Inhibition of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinases 4 gene delivery. Arthritis Rheum 46:3361–3368PubMedCrossRef Celiker MY, Ramamurthy N, Xu JW, Wang M, Jiang Y, Greenwald R, Shi YE (2002) Inhibition of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinases 4 gene delivery. Arthritis Rheum 46:3361–3368PubMedCrossRef
Metadata
Title
Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population
Authors
H. J. Lee
G. H. Lee
S. Nah
K. H. Lee
H. Yang
Y. M. Kim
W. Chun
S. Hong
S. Kim
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0545-4

Other articles of this Issue 9/2008

Rheumatology International 9/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.